ArticleJournal of thoracic disease2025
Thromboelastography and interleukin-6 predict postoperative negative remodeling of descending aorta in patients with type A aortic dissection.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Negative remodeling (NR) is common in postoperative residual aortic dissection (AD) in patients with type A aortic dissection (AAD); however, reliable predictors for its assessment remain lacking. This study aimed to investigate the clinical value of thromboelastography (TEG) and interleukin-6 (IL-6) in predicting postoperative NR in patients with AAD. Methods: We analyzed patients who underwent total aortic arch replacement surgery for AAD between January 2020 and December 2021, and were monitored for 2 years postoperatively. All relevant data were collected and analyzed. Results: A total of 208 patients with AAD were included. The incidence of NR (group NR) in residual AD was 24.0% (n=50) with higher follow-up mortality (8.0% Conclusions: TEG and IL-6 levels were effective predictors of the risk of postoperative NR of residual AD in patients with AAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.